1h Free Analyst Time
The digital biomarkers market is forecasted to grow by USD 4429.71 mn during 2023-2028, accelerating at a CAGR of 21.04% during the forecast period. The report on the digital biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of neurological disorders, the increasing prevalence of CVDs, and the increasing adoption of smart wearables.
The digital biomarkers market is segmented as below:
By End-user
- Healthcare companies
- Healthcare providers
- Others
By Type
- Wearables
- Mobile application
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the digital biomarkers market covers the following areas:
- Digital biomarkers market sizing
- Digital biomarkers market forecast
- Digital biomarkers market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global digital biomarkers market: Alphabet Inc., Altoida Inc, Aural Analytics Inc, Brainomix Ltd., Chugai Pharmaceutical Co. Ltd., Clinical Ink Inc., Empatica Inc. , eResearchTechnology GmbH, EVOCAL Health GmbH, F. Hoffmann La Roche Ltd., IMVARIA Inc., Invitrace, IQVIA Holdings Inc., IXICO plc, Koneksa Health Inc., Neurotrack Technologies Inc., PureTech Health Plc, Science Group Plc., VivoSense Inc., and APPLICARE.AI.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing focus on personalized treatments.'
According to the report, one of the major drivers for this market is the increasing prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alphabet Inc.
- Altoida Inc
- Aural Analytics Inc
- Brainomix Ltd.
- Chugai Pharmaceutical Co. Ltd.
- Clinical Ink Inc.
- Empatica Inc.
- eResearchTechnology GmbH
- EVOCAL Health GmbH
- F. Hoffmann La Roche Ltd.
- IMVARIA Inc.
- Invitrace
- IQVIA Holdings Inc.
- IXICO plc
- Koneksa Health Inc.
- Neurotrack Technologies Inc.
- PureTech Health Plc
- Science Group Plc.
- VivoSense Inc.
- APPLICARE.AI
